3.2. Primary and Secondary Outcomes
Body weight significantly increased in the whole cohort at the end of the study (79 (69–85) vs. 81 (68–88) kg, No statistically significant differences were observed In abdominal, arm, or calf perimeters after 24 weeks of intervention (According to the RF ultrasound, adipose tissue, muscle area, and muscle circumference tended to decrease in the intervention group; specifically, adipose tissue decreased 0.1 cm (Regarding functionality tests, no significant change in handgrip strength was observed, but mobility significantly improved in all patients by 12.6 s according to the up-and-go test (Regarding the biochemical data, hemoglobin increased by 0.4 mg/dL in all patients (Self-reported QoL significantly increased in all patients, from 72.5 (50–85) at baseline to 80 (80–90) (When heart functionality was evaluated, LVEF increased in the whole cohort (38.7% ± 16.6 vs. 42.2% ± 8.9, Age- and sex-adjusted analysis revealed that nutritional support, baseline LVEF, NT-proBNP, body composition parameters, and functionality tests were not associated with mortality or new hospital admissions in this cohort (some representative parameters are depicted in 